{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:25:15Z","timestamp":1793849115332,"version":"4.6.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clinthera.2026.07.013","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:23:08Z","timestamp":1787257388000},"page":"1076-1083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bridging Early Feasibility and Pivotal Trials: Insights From Transcatheter Tricuspid Valve Interventions"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2142-7512","authenticated-orcid":false,"given":"Monica","family":"Tocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Capuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Matsubayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Tseng-Rogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne","family":"Kayser-Soltys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Blankenspoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Decandia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Adinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuditta","family":"Callea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.07.013_sbref0001","series-title":"Investigational Device Exemptions (IDEs) for Early Feasibility Medical Device Clinical Studies, Including Certain First-in-Human (FIH) Studies","year":"2013"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0002","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2016.07.769","article-title":"Overcoming the challenges of conducting early feasibility studies of medical devices in the United States","volume":"68","author":"Holmes","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0003","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.jacc.2020.10.019","article-title":"Early feasibility studies for cardiovascular devices in the United States: JACC state-of-the-art review","volume":"76","author":"Holmes","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0004","unstructured":"21st Century Cures Act. FDA. 2025. Accessed February 25, 2026. https:\/\/www.fda.gov\/regulatory-information\/selected-amendments-fdc-act\/21st-century-cures-act."},{"key":"10.1016\/j.clinthera.2026.07.013_bib0005","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.jcin.2018.05.010","article-title":"The 21st century cures act and early feasibility studies for cardiovascular devices: what have we learned, where do we need to go?","volume":"11","author":"Holmes","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0006","unstructured":"Regulation \u2013 2017\/745 \u2013 EN \u2013 Medical Device Regulation \u2013 EUR-Lex. Accessed September 30, 2025. https:\/\/eur-lex.europa.eu\/eli\/reg\/2017\/745\/oj\/eng."},{"key":"10.1016\/j.clinthera.2026.07.013_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2023.110908","article-title":"Comparison of the international regulations for medical devices-USA versus Europe","volume":"54","author":"Fink","year":"2023","journal-title":"Injury"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0008","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/eurheartj\/ehaf069","article-title":"Priorities for medical device regulatory approval: a report from the European Society of Cardiology Cardiovascular Round Table","volume":"46","author":"Windecker","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0009","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17434440.2022.2075729","article-title":"Recommendations for the design and implementation of an Early Feasibility Studies program for medical devices in the European Union","volume":"19","author":"Callea","year":"2022","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jtcvs.2017.09.141","article-title":"Severity of tricuspid regurgitation is associated with long-term mortality","volume":"155","author":"Kelly","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.carrev.2023.09.005","article-title":"The medical device development ecosystem: current regulatory state and challenges for future development: a review","volume":"60","author":"Holmes","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0012","unstructured":"MDCG 2025-9 Guidance on Breakthrough Devices (BtX) under Regulations 2017\/745 & 2017\/746. https:\/\/health.ec.europa.eu\/document\/download\/edca94c7-62ab-4dd5-8539-2b347bd14809_en?filename=mdcg_2025-9.pdf."},{"key":"10.1016\/j.clinthera.2026.07.013_bib0013","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.jcin.2024.05.036","article-title":"Percutaneous edge-to-edge repair for tricuspid regurgitation: 3-year outcomes from the TRILUMINATE study","volume":"17","author":"Nickenig","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jacc.2020.11.038","article-title":"Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation","volume":"77","author":"Lurz","year":"2021","journal-title":"JACC"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0015","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/eurheartj\/ehad667","article-title":"Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study","volume":"44","author":"Kodali","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0016","unstructured":"Puri R. TRICAV-1 US EFS: early insights. PCR London Valves 2025. https:\/\/media.pcronline.com\/diapos\/PCRLondon2025\/25196-20251116_1716_Simulation_Learning_Room_Puri_Rishi_00_%28139917%29\/Puri_Rishi_20251116_1715_Simulation_Learning_Room.pdf."},{"key":"10.1016\/j.clinthera.2026.07.013_bib0017","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa2401918","article-title":"Transcatheter valve replacement in severe tricuspid regurgitation","volume":"392","author":"Hahn","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0018","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1007\/s00210-025-03843-3","article-title":"Evidence-based recommendations for comprehensive regulatory guidelines in medical devices: the imperative for global harmonization","volume":"398","author":"Rimpi","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.clinthera.2026.07.013_bib0019","doi-asserted-by":"crossref","first-page":"1636269","DOI":"10.3389\/fmed.2025.1636269","article-title":"Harmonizing health: a global analysis of pharmaceutical regulatory activities by international regulatory organizations","volume":"12","author":"Dangy-Caye","year":"2025","journal-title":"Front Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:33:40Z","timestamp":1793846020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826002754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0149291826002754"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.013","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging Early Feasibility and Pivotal Trials: Insights From Transcatheter Tricuspid Valve Interventions","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}